Cannara Biotech (TSXV:LOVE) Change In Inventory : C$-2.58 Mil (TTM As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Change In Inventory?

Cannara Biotech's change in inventory for the quarter that ended in Nov. 2024 was C$-1.28 Mil. It means Cannara Biotech's inventory increased by C$1.28 Mil from Aug. 2024 to Nov. 2024 .

Cannara Biotech's change in inventory for the fiscal year that ended in Aug. 2024 was C$-3.98 Mil. It means Cannara Biotech's inventory increased by C$3.98 Mil from Aug. 2023 to Aug. 2024 .

Cannara Biotech's Total Inventories for the quarter that ended in Nov. 2024 was C$41.74 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cannara Biotech's Days Inventory for the quarter that ended in Nov. 2024 was 250.67.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cannara Biotech's Inventory Turnover for the quarter that ended in Nov. 2024 was 0.36.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannara Biotech's Inventory-to-Revenue for the quarter that ended in Nov. 2024 was 1.63.

Cannara Biotech Change In Inventory Historical Data

The historical data trend for Cannara Biotech's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Change In Inventory Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Change In Inventory

Get a 7-Day Free Trial

-2.47

-3.37

-8.23

-8.33

-3.98

Cannara Biotech Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Change In Inventory	Get a 7-Day Free Trial															-2.68	-2.95	0.46	1.20	-1.28

Cannara Biotech Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.58 Mil.

Cannara Biotech (TSXV:LOVE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cannara Biotech's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	40.9065	/	14.891	*	365 / 4
	=	250.67

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cannara Biotech's Inventory Turnover for the quarter that ended in Nov. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	14.891	/	40.9065
	=	0.36

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cannara Biotech's Inventory to Revenue for the quarter that ended in Nov. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	40.9065	/	25.07
	=	1.63

Cannara Biotech Change In Inventory Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Nicholas Sosiak	Senior Officer
Donald John Olds	Director
Olymbec Investments Inc.	10% Security Holder
Derek Elan Stern	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder